中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
36期
7-7,10
,共2页
支气管扩张%咯血%垂体后叶素%酚妥拉明
支氣管擴張%咯血%垂體後葉素%酚妥拉明
지기관확장%각혈%수체후협소%분타랍명
Bronchiectasis%Hemoptysis%Pituitrin%Phentolamine
目的:探讨采用垂体后叶素联合酚妥拉明治疗支气管扩张合并咯血患者的临床疗效。方法按照数字随机表法将我院近年来收治的86例支气管扩张合并咯血患者平均分为观察和对照2组,所有患者均给予镇咳、化痰、抗感染、对症支持等常规治疗,观察组患者在此基础上应用垂体后叶素联合酚妥拉明治疗,比较两组患者的治疗总有效率。结果观察组患者治疗总有效率为95.3%,显著高于对照组患者的76.7%,组间差异可见统计学意义(P<0.05)。观察组患者用药过程中2例出现腹痛,2例出现胸闷,患者均能耐受,未影响治疗。结论垂体后叶素与酚妥拉明联合应用是一种治疗支气管扩张合并咯血患者的理想方法,应在临床大力推广使用。
目的:探討採用垂體後葉素聯閤酚妥拉明治療支氣管擴張閤併咯血患者的臨床療效。方法按照數字隨機錶法將我院近年來收治的86例支氣管擴張閤併咯血患者平均分為觀察和對照2組,所有患者均給予鎮咳、化痰、抗感染、對癥支持等常規治療,觀察組患者在此基礎上應用垂體後葉素聯閤酚妥拉明治療,比較兩組患者的治療總有效率。結果觀察組患者治療總有效率為95.3%,顯著高于對照組患者的76.7%,組間差異可見統計學意義(P<0.05)。觀察組患者用藥過程中2例齣現腹痛,2例齣現胸悶,患者均能耐受,未影響治療。結論垂體後葉素與酚妥拉明聯閤應用是一種治療支氣管擴張閤併咯血患者的理想方法,應在臨床大力推廣使用。
목적:탐토채용수체후협소연합분타랍명치료지기관확장합병각혈환자적림상료효。방법안조수자수궤표법장아원근년래수치적86례지기관확장합병각혈환자평균분위관찰화대조2조,소유환자균급여진해、화담、항감염、대증지지등상규치료,관찰조환자재차기출상응용수체후협소연합분타랍명치료,비교량조환자적치료총유효솔。결과관찰조환자치료총유효솔위95.3%,현저고우대조조환자적76.7%,조간차이가견통계학의의(P<0.05)。관찰조환자용약과정중2례출현복통,2례출현흉민,환자균능내수,미영향치료。결론수체후협소여분타랍명연합응용시일충치료지기관확장합병각혈환자적이상방법,응재림상대력추엄사용。
Objective?To?investigate?the?clinical?effect?of?pituitrin?combined?with?phentolamine?in?the?treatment?of?patients?with?bronchiectasis?with?hemoptysis.?Methods?In?our?hospital?in?recent?years?in?86?cases?of?bronchiectasis?with?hemoptysis?were?divided?into?observation?and?control?group?2?in?accordance?with?the?digital?random?table?method,?all?patients?were?given?the?antitussive,?expectorant,?anti?infection,?symptomatic?and?supportive?treatment,?observation of pituitary application group patients based on Pituitrin and phentolamine treatment, comparison two groups of patients and the total efifciency. Results?In the observation group, the total effective rate was 95.3%, signiifcantly higher than the control group of 76.7%patients, the differences between groups showed statistical signiifcance(P<0.05).?Observation?group?patients?in?2?patients?had?abdominal?pain,?2?cases?of?chest?tightness,?patients?can?be?well?tolerated,?did?not?affect?the?treatment.?Conclusion?Pituitrin?and?phentolamine?combined?application?is?an?ideal?method?for?the?treatment?of?patients?with?bronchiectasis?with?hemoptysis,?should?be?popularized?in?clinic.